The Inventurus Knowledge Solutions (IKS) IPO has entered its third day, attracting significant attention from investors. Here’s a detailed update on the Grey Market Premium (GMP), subscription status, expert reviews, and whether to apply.
GMP and Subscription Status
The IPO’s Grey Market Premium (GMP) is currently trading at ₹55-₹60, indicating positive investor sentiment. As of Day 2, the IPO has been subscribed 4.3 times, with strong interest from retail and Qualified Institutional Buyers (QIBs). The retail portion has been oversubscribed, showing robust demand among small investors.
Source:- bbc news
IPO Details
Price Band: ₹650-₹700 per share
Issue Size: ₹1,200 crore (including fresh issue and offer for sale)
Objective: Funds will be utilized for debt repayment, business expansion, and working capital requirements.
Source:- news 18
Expert Review
Analysts have a neutral to positive outlook on IKS, citing its steady financial performance and strong position in healthcare knowledge outsourcing. The company’s FY24 revenue growth and healthy margins add to its appeal. However, concerns include its reliance on a few key clients and the competitive nature of the sector.
Should You Apply?
Investors with a high-risk appetite and a focus on growth-oriented mid-cap stocks may find IKS an attractive option, especially given its leadership in the healthcare outsourcing niche. However, cautious investors should consider potential volatility and evaluate long-term prospects.
Verdict
The IKS IPO offers decent growth potential backed by industry demand and operational excellence. With a promising GMP and oversubscription trends, it’s a suitable option for short-term gains. However, long-term investors should assess risks before applying.
Share your views in the comments
